Passage of fetal bowel movement (meconium) is common (in about one out of six births), and in some the staining of the amniotic fluid is a sign of fetal distress. Inhalation of meconium (aspiration syndrome, in upto one out of five to eight such births) just before or at birth may be preventable by a coordinated approach by well-trained and informed birth attendants. Respiratory failure secondary to meconium aspiration syndrome (MAS) remains a major cause of morbidity and mortality in the neonatal population. Infants with hypoxemic respiratory failure because of MAS, persistent pulmonary hypertension of the newborn and pneumonia/sepsis have an increased survival with extracorporeal membrane oxygenation (ECMO). Other treatment options earlier limited to inotropic support, continuous airway pressure (CPAP), conventional ventilatory management, respiratory alkalosis, paralysis and intravenous vasodilators have been replaced by synchronized intermittent mandatory ventilation (SIMV), high-frequency oscillatory ventilation (HFOV), surfactant and inhaled nitric oxide (iNO). HFOV has been advocated for use to improve lung inflation while potentially decreasing lung injury through volutrauma. Other reports describe the enhanced efficacy of HFOV when combined with iNO. Subsequent to studies reporting that surfactant deficiency or inactivation may contribute to neonatal respiratory failure, exogenous surfactant therapy has been implemented with apparent success. Recent studies have shown that iNO therapy in the neonate with hypoxemic respiratory failure can result in improved oxygenation and decreased need for ECMO. However, these innovative interventions are costly, require a sophisticated infrastructure and are not universally accessible. In this paper, a context of systems-approach for prenatal, natal and postnatal management of babies delivered through meconium stained amniotic fluid (MSAF) so that adverse outcomes are minimized and the least number of babies require innovative ventilatory support is described. Previously reported data from a single urban perinatal center (Philadelphia, PA, USA), over a 6-year period (1995)(1996)(1997)(1998)(1999)(2000), demonstrated that 14.5% (3370/23 175 of live births babies were delivered with MSAF. These data also showed that 4.6% of babies (155/ 3370) with MSAF sustained MAS. Overall, 26% of babies (40/155) with MAS needed ventilatory support (or 0.17% of all live births); of these, only 20% (8/40 or 0.035% of live births) needed innovative ventilatory support. None died or needed ECMO. These data describe the components for a systems approach to prevent and manage adverse outcomes related to MSAF at the regional level II or III perinatal center. Replication of a similar strategy may be more relevant to cost containment and be a safer approach for neonates at risk for MAS-related respiratory failure. This paper assess the evidence for pivotal steps needed to prevent MAS and ensuing neonatal death and disease in the context of diverse perinatal health services.
Introduction
Optimizing the management of infants born with meconium staining, relevant to the Indian macro-and micro-health environment, may prevent adverse outcomes owing to perinatal asphyxia, meconium aspiration syndrome (MAS), and ensuing respiratory failure. The predictive risk factors for MAS in infants delivered through meconium-stained amniotic fluid (MSAF) have not been ascertained prospectively. On the basis of a retrospective study reported by Usta et al., 1 odds ratio >3 was identified when an infant's delivery was associated with the (a) induction for non-reassuring fetal heart rate (FHR) pattern, (b) need for endotracheal intubation (ET), (c) Apgar p3 at 1 min or (d) need for a Cesarean section (Table 1 ). This study informed and influenced clinical delivery room practice for several years. In addition, the management of meconium at the time of birthing has been examined from two perspectives: (i) suctioning of the meconium from an infant's upper airway after delivery of the head but before delivery of the shoulders (intrapartum suctioning, oronasopharyngeal suctioning) and (ii) suctioning of an infant's trachea immediately after birth with an ET. Recommendations for intrapartum suctioning for meconium had been based on consensus of studies that have yielded conflicting results about the value of intrapartum oronasopharyngeal suctioning of infants born with MSAF. A more recent large multicenter randomized trial found that intrapartum suctioning of meconium does not reduce the incidence of MAS. The latter study has led the International Liaison Committee on Resuscitation 2 or ILCOR to recommend against routine intrapartum oronasopharyngeal suctioning for infants born with MASF. On the other hand, the current recommendation for ET suctioning is based on a pivotal randomized, controlled trial that showed that ET intubation and suctioning for vigorous infants at birth offers no benefit. It is also known that the benefit of ET suctioning in meconium-stained, depressed infants has not been systematically studied. However, the current ILCOR treatment recommendation is that meconium-stained, depressed infants should receive ET suctioning immediately after birth and before stimulation, presuming that the equipment and expertise is available and that ET suctioning is not necessary for infants with MASF who are vigorous. The relevance for application of ILCOR recommendations to a population with diverse access to perinatal health care has been questioned. The studies and recommendations cited by ILCOR are reported from those conducted in developed nations and nations with sophisticated medicalized health-care systems. These recommendations may not be applicable in areas with low income resources, births conducted at home or limited perinatal access to evidence-based medical care. 3 Dramatic improvements in the overall birthing conditions and the continuing advances in perinatal-neonatal practices during the last decade have yet to universally affect the unacceptably high risk of morbidity and mortality in the neonatal population. Earlier experiences have led us to believe that building an interdisciplinary leadership approach that lends itself to a systems approach would provide innovative strategies to bridge the existing access barriers in micro-and macro-health environments of diverse social and cultural backgrounds.
Global perspective of births with MASF Meconium-stained amniotic fluid is found in 7 to 20% of pregnancies at the time of delivery. [3] [4] [5] [6] [7] MSAF is associated with fetal acidosis, abnormalities in FHRs and low Apgar scores, suggesting hypoxia as the stimulant of passage of meconium in utero. 8, 9 The most severe condition associated with meconium passage in utero, MAS, occurs in 2 to 9% of neonates born through MASF and has a high mortality rate of 40%. 5, 7, [10] [11] [12] [13] At delivery, meconium is found below the vocal cords in 20 to 45% of neonates born through MSAF. 4, 10, 13, 14 If it has not been aspirated into the lungs, the removal of meconium from the airways before the first breath can reduce the incidence of MAS. This preemptive removal of meconium from the airways can be performed at the time of delivery (intrapartum suctioning) or immediately after delivery (postpartum suctioning). Intrapartum suctioning consists of clearing the mouth, pharynx and nose with either a large-bore suction catheter (12 to 14 mm caliber) or a bulb syringe as soon as the head is delivered but before delivery of the shoulders. Postpartum suctioning consists of intubating and suctioning the trachea before performing the other steps of resuscitation. Respiratory failure is a major cause of morbidity and mortality in the neonatal population. Infants with hypoxemia develop respiratory failure because of MAS, persistent pulmonary hypertension of the newborn and pneumonia/sepsis. Recently, Bhutani et al. 15 suggested a system-based strategy comprising the prenatal, natal and postnatal management of babies delivered through MASF, so that the adverse outcomes are minimized and the least number of babies require innovative ventilatory support. At an urban perinatal center in Pennsylvania, over a 6-year period Components of a systems approach to prevent MAS Interdisciplinary health-care perspectives Depending on the likelihood of MAS as a potential but significant neonatal morbidity, the development of a 'rapid response team' was envisioned as an institutional policy (prevalent in most US birthing facilities) with the goal of modulating an intensive care nursery census and also the risk of adverse neonatal outcomes. The potential reduction in neonatal mortality and cost containment would be the anticipated advantages of team-based interventions. The team would constitute the obstetrician, pediatrician (and/or neonatologist), the perinatal nurses (obstetrical and neonatal) and the family, supported by the maternal child health administrators.
Although the obstetrician has a task-oriented responsibility to take care of the mother and the family through the performance and delivery of quality of care services in the delivery room, a personal agenda is to strive for a 'HAPPY' family experience. This is achieved through minimally atraumatic birthing with the prevention of fetal hypoxemia and acidosis, and an effective management of maternal and personnel stress. The perinatal birthing nurse provides support, educates and cares for the family during the changing birthing environment. A seemingly benign process has the potential of disintegration as erstwhile birthing plans are shelved. Participation in clinical management includes fetal monitoring and appropriate availability and documentation of instrumentation. A pediatrician needs to be accessible in a timely manner for unpredictable and 'stat' calls and have the skills and ability to perform (without anxiety) in an acute stressful response. In addition, the pediatrician needs to clarify any confusion on the amount of meconium staining and the status of fetal well-being, and to make a decision of the likelihood of an elective neonatal intubation. The family perspectives are overwhelmed by the sudden medicalization of the birthing process and are aggravated by anxiety, stress, interruption of bonding and loss of privacy with unanticipated instrumentations and participation of often unselected and unsolicited providers.
Performance and judgment of the 'rapid response team' Besides being awake and alert, the team needs to have a physiologic understanding and risk assessment ability of the clinical progression of MAS. Credentialing for neonatal resuscitation, performance standards and intubation skills of the team are now routine at all birthing facilities. The team needs to acquire the prenatal history and the evolving perinatal events, directly observe the natal events and render as well as execute postnatal management decisions. The relevant prenatal history acquired through the attending obstetrician and nurse would include the intensity of meconium staining, status of fetal well-being and FHR patterns and fetal pH (if measured) data on the use of amnioinfusion, and risk factors for perinatal infections and for any maternal-placental complications. The latter include a prolonged second stage of labor, abruption of the placenta, placenta previa or cord accidents (nuchal cords, true knots, cord compression and cord prolapse), abnormal fetal presentations, maternal hypertension, pre-eclampsia, intrauterine growth retardation, post-maturity or placental calcifications. FHR monitoring is a predominant method to assess fetal oxygenation in labor; however, it is a nonspecific, indirect and inaccurate measure of fetal hypoxia and acidosis. Electronic fetal monitoring is associated with increased Cesarean section because of 'non-reassuring' FHR patterns. These include FHR between 100 and 120 with no accelerations, FHR <100 beats/min with accelerations, increased heart rate variability of >25 beats/min for >30 min, late decelerations (>1 per 30 min), persistent late decelerations (>50% of contraction), fetal tachycardia (>160 beats/min) or a sinusoidal pattern. Natal observations provide an assessment of fetal handling during instrumentation (such as vacuum extractions, forceps delivery and neck manipulation as well as the handling of the baby's head by the obstetrician, and the presence of nuchal cords. Once the infant's head is delivered, the activity and vigor status and the resuscitation process are initiated, as indicated. Once the infant is stabilized, the umbilical cord status is ascertained meconium staining, presence of venous clots and insertion at the placenta.
Postnatal management decisions
When meconium is present in the amniotic fluid, the current ILCOR recommendations are to defer suctioning of the hypopharynx on delivery of the head. If the meconium-stained newly born infant has absent or depressed respirations, heart rate or muscle tone, residual meconium should be suctioned from the trachea. Ventilation is of primary concern. The role of intrapartum suctioning has been a subject of controversy and recent research.
Studies in favor of intrapartum suctioning. Intrapartum suctioning has been considered standard practice for more than 25 years on the basis of a study by Carson et al. 16 In this before-and-after trial, they reported an incidence of 1.9% (n ¼ 947) for MAS with a mortality rate of 28% during a period when only postpartum suctioning was performed, as compared with MAS incidence of 0.4% (n ¼ 273, P ¼ 0.07) and no deaths when intrapartum suctioning was also performed in addition to postpartum suctioning. The effectiveness of intrapartum suctioning was confirmed in a subset of patients enrolled in a multicenter randomized controlled trial looking into the efficacy of postpartum suctioning in vigorous newborns. 17 In this study by Wiswell et al., the incidence of MAS was 8.5% in infants who did not have intrapartum suctioning (n ¼ 94), as compared with 2.7% in infants who had intrapartum suctioning (n ¼ 54;
Equivocal studies. Two prospective and non-randomized clinical trials by Falciglia et al.
10,14 compared early suctioning (suctioning by the obstetrician before delivery of the thorax) and late suctioning (suctioning by the obstetrician after delivery of the thorax) and showed no difference in the incidence of MAS. In the first study, no differences in the rate of meconium below the cords (36 vs 37%) or the incidence of MAS (20% in each group) between early and late suctioning were noted. 8 The second study reported a higher rate of meconium below the cords (53%) among the early suctioning group compared with the late suctioning group, which had a rate of 36% (P<0.001), but there was no difference in the incidence of MAS between the two groups (P>0.05). 13 Rossi et al.
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reported that despite intrapartum suctioning, meconium was present in the trachea in 37% (n ¼ 238) of neonates born through MSAF, and MAS developed in 9.2% of cases.
Studies that do not recommend intrapartum suctioning.
A large multicenter, randomized controlled clinical trial enrolled 2514 patients with MSAF with the desired goal of assessing the effectiveness of intrapartum suctioning for the prevention of MAS.
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This study also examined the effect of intrapartum suctioning in high-risk subgroup infants (those with thick MSAF) with abnormal FHR patterns, infants with delivery by Caesarian section and infants needing resuscitation in the delivery room. This study showed that intrapartum suctioning does not reduce the incidence of MAS (relative risk (RR): 0.9, 95% confidence interval (CI): 0.6 to 1.3), need for mechanical ventilation (RR: 0.8, 95% CI: 0.4 to 1.4) and mortality (RR: 0.4, 95% CI: 0.1 to 1.5).
Current ILCOR recommendations. On the basis of these large studies, the current guidelines of the American Academy of Pediatrics and the American Heart Association through the Neonatal Resuscitation Program and Pediatric Working Group of the ILCOR 1 no longer recommend routine intrapartum oronasopharyngeal suctioning by an obstetrician before delivery of the shoulder. Discretionary intrapartum suction also remains a standard of care. This decision is not based on a meta-analysis, but, on the basis of consensus of opinions that are most relevant to the care of infants already affected, improved the dating of pregnancy by a lowering of the gestational age at birth (fewer deliveries for pregnancies >41 weeks), earlier recognition of fetal distress and improved access to sophisticated birthing facilities in developed nations. The other currently recommended approach to prevent MAS is immediate postnatal ET suctioning in non-vigorous (depressed) babies born through MSAF. In nations and communities with improved perinatal health-care access, an observational and non-intervention strategy is indicative of eminent and cautious practice. Mandatory intrapartum suctioning in babies born through MSAF is being discontinued, largely on the basis of a single large randomized controlled study conducted in a setting with facilities for intensive fetal monitoring, prompt response to fetal distress and 24 h availability of personnel trained in neonatal resuscitation, including postnatal intubation and ET meconium suctioning.
Impact of different clinical settings. Most of the deliveries in these countries take place either at home or at ill-equipped and understaffed hospitals. The profile of women and their neonates born in a developing country setting contrasts sharply with that of developed countries. Even in the study by Vain et al., 18 which included 11 sites in Argentina, a middle-income country, the clinico-epidemiologic profile was not comparable with the diverse environment and communities encountered in India (see Table 2 ). The Indian experiences document high rates of pregnancy-related complications such as pregnancy-induced hypertension, oligohydramnios, intrauterine growth retardation and post-maturity. In addition, in the Indian settings, postnatal intubation and ET suctioning of non-vigorous infants could be jeopardized if discretionary recommendations are made without specific, practical and easily implemented algorithms.
Low-and middle-income nations account for the majority of the 130 million live births and 4 million neonatal deaths occurring each year. 19 Therefore, we speculate that the relatively simpler and easier techniques to perform intrapartum suctioning and the availability of appropriate biotechnologies, such as large-bore, portable, disposable and easily manipulated suction devices for the mouth, nose and/or trachea that are non-traumatic, sterile and independent of wall suction, may still have a role in the prevention of MAS, whereas improvements of perinatal health-care access are initiated and implemented.
Understanding immediate postnatal tachypnea and clinical signs
The most frequent benign etiology for tachypnea is respiratory compensation for metabolic acidosis as evidenced by hypocapnia and normoxemia. On the other hand, onset of respiratory disease would be evident by hypercapnia and hypoxemia. Worrisome tachypnea could be due to air leaks (pneumothoraces and pneumomediastinum), atelectasis, aspiration, pneumonia and, most of all, concern for incipient persistent pulmonary hypertension. Peripheral cyanosis (manifested by blue toes) would require continuous pulse oximetry to document normoxemia and observation for expectant care. Central cyanosis (as manifested by blue lips) would require an evaluation for hemodynamic changes with handling, evaluation of response to inspired oxygen and continued observation in a nursery environment for continued cardiorespiratory environment. Crystalloid infusion may be helpful for infants with 'benign tachypnea' if the capillary perfusion is compromised. In such conditions, the measurements of arterial blood gases or chest radiographs may not be necessary. If metabolic acidosis is documented for persistent tachypnea with hypoxemia, base correction with bicarbonate is not essential and crystalloid infusion is likely to be sufficient. Persistent tachypneaassociated hypoxemia and hypercapnia would be indications for a chest radiograph evaluation. When an infant is stabilized, postnatal gastric suction, presumably to prevent postnatal aspiration, is not evidence-based and, similarly, gastric lavage is not necessary. Infants do need to be monitored for airway stability and subsequent choking/bradycardia.
Subsequent postnatal management
Infants are likely to need close glucose monitoring for hypoglycemia because of concomitant risk factors. Intravenous dextrose infusions and delayed enteral nutrition need to be considered for persistent tachypnea (owing to hypoxemia and/or hypercapnia), low Apgar scores and hypoglycemia. Screening for sepsis would be based on the presence of known maternal risk factors or an abnormal chest radiograph. The need for continued cardiorespiratory monitoring, parenteral nutrition and concerns for sepsis are the most common reasons for continued neonatal observation and management. Within about 30 min, age, and color changes should have stabilized.
Similarly, within about 6 h, age, any transient grunting, flaring and retractions should stabilize. Deviations from these time frames should initiate a process of a more intense evaluation. The absence of any signs of sepsis or cardiorespiratory distress beyond 24 h of age is likely to exclude the MAS.
Conclusions
A systems approach that provides for a well-coordinated and trained 'rapid response team' for meconium-stained births is likely to implement an evidence-based intervention and effectively manage a potential catastrophic outcome for the infant, the family and the staff. Classic practices of maintaining equipoise in the delivery room require working (and communicating) with the attending obstetrician and nursing staff and supporting the education of the family. The team's approach is to be expectant but prepared to intubate the infant. The team's role is to monitor the progress of labor, fetal status, fetal data and family status and to be prepared to interact, interpret, intervene and initiate support as needed. These data from a single US center also illustrate the complex interactions of technologies used during a birthing practice that could have both potentially useful (airway clearance) and/or deleterious effects because of the combinations of trauma, introduction or aggravation of infection and/or interference of gas exchange. Several of the components of clinical practice are based on evidence, and their implementation in practice may need further validation or resolution by consensus. There is a health and societal need to establish guidelines for practice at birthing facilities in the United States. Consistency in practice may lead to cost containment, even though the cost-effectiveness of such an approach has not been validated. Methodological inquiry, evidentiary analysis and reassessment of both clinical and biotechnological options would better inform the development of a practical stepwise algorithm to optimize bedside care.
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